Methylated genes as new cancer biomarkers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
M J DuffyEORTC PathoBiology Group

Abstract

Aberrant hypermethylation of promoter regions in specific genes is a key event in the formation and progression of cancer. In at least some situations, these aberrant alterations occur early in the formation of malignancy and appear to be tumour specific. Multiple reports have suggested that measurement of the methylation status of the promoter regions of specific genes can aid early detection of cancer, determine prognosis and predict therapy responses. Promising DNA methylation biomarkers include the use of methylated GSTP1 for aiding the early diagnosis of prostate cancer, methylated PITX2 for predicting outcome in lymph node-negative breast cancer patients and methylated MGMT in predicting benefit from alkylating agents in patients with glioblastomas. However, prior to clinical utilisation, these findings require validation in prospective clinical studies. Furthermore, assays for measuring gene methylation need to be standardised, simplified and evaluated in external quality assurance programmes. It is concluded that methylated genes have the potential to provide a new generation of cancer biomarkers.

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M FrommerC L Paul
Apr 1, 1993·Electrophoresis·Y HayashizakiS Wada
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Jun 15, 1997·Nucleic Acids Research·Z Xiong, P W Laird
Feb 21, 1998·Nucleic Acids Research·P Laurent-PuigT Soussi
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·S A BelinskyJ G Herman
Nov 26, 1998·Journal of Cancer Research and Clinical Oncology·T KellerP Leonhardt
Feb 9, 1999·Human Molecular Genetics·T H HuangD E Laux
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ToyotaJ P Issa
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·G J NuovoJ G Herman
Nov 7, 1999·The American Journal of Pathology·M EstellerJ G Herman
Mar 29, 2000·Nucleic Acids Research·C A EadsP W Laird
Apr 6, 2000·Journal of the National Cancer Institute·M EstellerJ G Herman
Apr 18, 2000·Mutation Research·A E Pegg
Aug 16, 2000·Scandinavian Journal of Clinical and Laboratory Investigation·J Watine
Nov 9, 2000·The New England Journal of Medicine·M EstellerJ G Herman
Jul 19, 2001·Journal of the National Cancer Institute·M S PepeY Yasui
Nov 22, 2001·Journal of the National Cancer Institute·C JerónimoD Sidransky
Feb 28, 2002·Nucleic Acids Research·Péter AdorjánAlexander Olek
May 16, 2002·Journal of the National Cancer Institute·Lanlan ShenJean-Pierre J Issa
Jun 6, 2002·Journal of the National Cancer Institute·David M EuhusAdi F Gazdar
Jun 21, 2002·European Urology·Carsten GoesslKurt Miller
Aug 3, 2002·Oncogene·Martin Widschwendter, Peter A Jones
Nov 15, 2002·The New England Journal of Medicine·William C Hahn, Robert A Weinberg
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Philippe AnkerMaurice Stroun
Mar 8, 2003·The Lancet Oncology·Per Eystein Lønning
Apr 3, 2003·Nature Reviews. Cancer·Peter W Laird
Oct 7, 2003·Oncogene·Richard L Momparler
Nov 25, 2003·The EMBO Journal·Esteban BallestarManel Esteller
Jan 15, 2004·Nucleic Acids Research·Susan E CottrellKurt Berlin
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rachel KrassensteinPaul Cairns
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Essel DulaimiPaul Cairns
Apr 20, 2004·Lancet·Hannes M MüllerMartin Widschwendter
Aug 3, 2004·Nature Medicine·Bert Vogelstein, Kenneth W Kinzler
Aug 19, 2004·Journal of the National Cancer Institute·Miguel AlaminosManel Esteller

❮ Previous
Next ❯

Citations

May 21, 2011·Molecular Biology Reports·Xinbing SuiXiaotong Hu
Jun 29, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Anastasia A PonomaryovaPavel P Laktionov
Jul 2, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K P M SuijkerbuijkE van der Wall
Jun 4, 2011·Molekuliarnaia biologiia·A A PonomarevaV V Vlasov
Oct 27, 2009·Future Oncology·John Wm MartensNadia Harbeck
Nov 30, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Cathy B MoelansPaul J van Diest
Jun 19, 2012·Expert Review of Molecular Diagnostics·Thomas MikeskaAlexander Dobrovic
Jun 3, 2015·International Journal of Oncology·Giulio CabriniRoberto Gambari
Aug 22, 2012·The Journal of Urology·Linda SullivanAntoinette S Perry
Apr 10, 2012·Taiwanese Journal of Obstetrics & Gynecology·Ming-Cheng ChangCheng-Yang Chou
Mar 1, 2012·International Journal of Cancer. Journal International Du Cancer·Alexander B PhilippFrank T Kolligs
Feb 17, 2010·Analytical Biochemistry·Johannes F WentzelPieter J Pretorius
Feb 6, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Rattaya AmornpisuttTemduang Limpaiboon
Dec 24, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Nicole BethgeGuro E Lind
Jul 16, 2010·Molecular Oncology·Jovana JovanovicVessela Kristensen
Jun 5, 2014·Inflammatory Bowel Diseases·Jan Däbritz, Trevelyan R Menheniott
Aug 27, 2017·Journal of Fluorescence·Morteza HosseiniDavood Ajloo
Dec 14, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Barbara BanelliMassimo Romani
Sep 22, 2010·Genetic Testing and Molecular Biomarkers·Dhirendra Singh YadavSujala Kapur
Aug 5, 2009·Journal of Clinical Gastroenterology·Manoop S BhutaniJason B Fleming
Apr 18, 2015·Clinical Chemistry·Michael J DuffyPatrick M M Bossuyt
Sep 7, 2011·Virchows Archiv : an International Journal of Pathology·Ga-Eon KimJung Han Yoon
Jul 7, 2019·Breast Cancer Research : BCR·Sònia PalomerasTeresa Puig
Nov 20, 2016·Current Opinion in Obstetrics & Gynecology·Madhu BagariaJamie N Bakkum-Gamez
Apr 25, 2019·Scientific Reports·Hwayeong CheonJoo-Hiuk Son
Nov 26, 2011·Archives of Gynecology and Obstetrics·Lu-Lu SunKeng Shen
Jun 27, 2018·International Journal of Molecular Sciences·Julio D AmigoAlejandro H Corvalán

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.